The report comes after Moncef Slaoui, the program’s chief adviser, resigned at the request of the incoming Biden team, in a plan that would see him stay in the role for a month to help with the transition.
Kessler, who led the FDA after being appointed by President George H.W. Bush to the top position in 1990 and served till 1997, will share top responsibilities for the initiative with Gustave Perna, the NYT report said.
The transition team did not immediately respond to a Reuters request for comment.
Kessler‘s move comes as the program is at a critical juncture. US President Donald Trump’s administration had aimed to give vaccine doses to 20 million Americans by the end of 2020, but fell far short of that target.
Only 11.1 million coronavirus shots had been administered as of Thursday out of more than 30 million doses distributed to states, according to data from the US Centers for Disease Control and Prevention.